Stockreport

Compass Therapeutics to Participate in Upcoming November Investor Events

Compass Therapeutics, Inc.  (CMPX) 
PDF BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developin [Read more]